Role of SR-4987 stromal cells in the modulation of doxorubicin toxicity to in vitro granulocyte-macrophage progenitors (CFU-GM)

Life Sciences

Volumn 65, Issue 5, 1999, Pages 513-523

  Pessina, Augusto ^b   Piccirillo, Michela ^c   Mineo, Elisabetta ^c   Catalani, Paolo ^a   Gribaldo, Laura ^a   Marafante, Erminio ^a   Neri, Maria Grazia ^c   Raimondi, Alessandro ^c  

^a JOINT RESEARCH CENTRE   (Italy)

^b Faculty of Veterinary Medicine   (Italy)

^c NONE

Author keywords

CFU GM; Doxorubicin; SR 4987 cells; Stromal cells

Indexed keywords

COLONY STIMULATING FACTOR; DNA TOPOISOMERASE; DOXORUBICIN; DOXORUBICINOL; DRUG METABOLITE;

ANIMAL CELL; ARTICLE; BONE MARROW TOXICITY; CELL PROTECTION; COLONY FORMING UNIT GM; CONTROLLED STUDY; DETOXIFICATION; ENZYME INHIBITION; MOUSE; NONHUMAN; STROMA CELL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL COMMUNICATION; CELL LINE; COCULTURE TECHNIQUES; DOXORUBICIN; HEMATOPOIETIC STEM CELLS; MICE; STROMAL CELLS;

ANIMALIA; MURINAE;

EID: 0033603195     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(99)00272-6     Document Type: Article

References (28)

1. C. Noble, J.F. Sina, In Vitro Toxicology, 6 187-195 (1993).
2. A. Deldar, R.V. House, D. Wierda, Methods in Immunotoxicology, Wiley-Liss Inc. (eds), Vol.I, 227-250, (1995).
3. D. Parent-Massin, D. Thouvenot, J. Pharmacol. Toxicol. Methods 30 203-207 (1993).
4. R.E. Parchment, M. Huang, C.L. Erickson-Miller, Toxicologic Pathology 21 241- 290 (1993).
5. T.R. Bradley, D. Metcalf, Aust. J. Exp. Biol. Med. Sci. 44 287-289 (1966).
6. L.H. Williams, K.B. Udupa, D.A. Lipschitz Exp. Hematol. 16 80-87 (1988).
7. B.A. Naughton, B. Sibanda, L. Azar, J. San Roman, Proc. Soc. Exp. Biol. Med. 199 481-490 (1991).
8. T.M. Dexter, T.D. Allen, L.G. Lajtha, J. Cell Physiol. 91 335-341 (1977).
9. K. Dorshkind, Ann. Rev. Immun. 8 111-137 (1990).
10. CF Muller-Sieburg, E. Deryugina, Stem Cells 3 477-486 (1995).
11. K.S. Cocke, L.W. Updyke, D. Wierda, In Vitro Toxicol. 6 243-256 (1993).
12. L. Gribaldo, J. Bueren, A. Deldar, P. Hokland, C. Meredith, D. Moneta, P. Mosesso, R. Parchment, D. Parent-Massin, A. Pessina, J. San Roman, G. Schoeters, ATLA 24 211-231 (1996).
13. L. Gribaldo, M. Piccirillo, S. Casati, A. Collotta, E. Mineo, A. Pessina, Toxicology in Vitro, 12 39-45 (1998).
14. A. Pessina, E. Mineo, M.G. Neri, L. Gribaldo, R. Colombi, R. Brambilla, G. Zaleskis, Cytotecnnology 8 93-102 (1992).
15. A. Pessina, M.G. Neri, E. Mineo, M. Piccirillo, L. Gribaldo, P. Brambilla, G. Zaleskis, P. Ujhazy, Exp. Hematol. 25 536-541 (1997).
16. A. Pessina, P. Brambilla, S. Villa, P. Mocarelli, Oncology 39 391-395 (1982).
17. T. Mossman, J. Immunol. Methods 65 55-63 (1983).
18. A.B. Kriegel, T.R. Bradley, G.S. Hodgson, I.K. McNiece, J. Immunol. Methods 103 93-102 (1987).
19. A. Pessina, L. Gribaldo, E. Mineo, M.G. Neri, Ind. J. Exp.Biol. 32 113-118 (1994).
20. A. Hamburger, S.E. Salmon, M.B. Kim, J.M. Trent, B.J. Soehlen, D.S. Albert, H.J. Schmidt, Cancer Res. 38 3438-3444 (1978).
21. A. Pessina, P. Brambilla, P. Mocarelli, Blut 49 45-51 (1984).
22. H.P. Vosberg, DNA Curr. Top. Microbiol. Immunol. 114 19-102 (1985).
23. H. Drake, G.A. Hofmann, S-M. Mong, J. O' Learly Bartus, R.P. Hertzbert, R.K. Johnson, M.R. Mattern, K. Mirabelli, Cancer Res. 49 2578-2583 (1989).
24. N. Osheroff, E.R. Shelton, D.L. Brutlog, J.Biol. Chem 258 9536-9543 (1983).
25. A.M. Deffie, J.K. Batra, G.J. Goldenberg, Cancer Res. 49 58-62 (1989).
26. L.J. Reed, H.A. Muench, Am. J. Hyg. 27 493-497 (1938).
27. G. Storm, P.A. Steerenberg, F. Emmen, M. Van Borssum Waalkes, D.J. Crommelin, Biochim. Biophys. Acta 965 136-145 (1988).
28. J.H. Doroshow, Anthracyclines and Anthracenediones in: Cancer Chemotherapy and Biotherapy, 2nd Ed. Lippincott-Raven Publishers, Philadelphia (1996).